Similar articles for PMID: 32354947

Year	Number of Results
1995	1
2003	2
2011	1
2012	2
2013	8
2014	8
2015	18
2016	16
2017	12
2018	15
2019	23
2020	6
2021	1
2022	0

1

Hepatic Angiosarcoma: Clinicopathologic Study With an Investigation of ROS1 Gene Rearrangements.

Jung H, Kim HN, Jang Y, Park CK, Shin SH, Ha SY. Jung H, et al. In Vivo. 2020 May-Jun;34(3):1463-1467. doi: 10.21873/invivo.11930. In Vivo. 2020. PMID: 32354947 Free PMC article.

2

Angiosarcoma of the Liver: Clinicopathologic Features and Morphologic Patterns.

Yasir S, Torbenson MS. Yasir S, et al. Am J Surg Pathol. 2019 May;43(5):581-590. doi: 10.1097/PAS.0000000000001228. Am J Surg Pathol. 2019. PMID: 30986799

3

Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors.

Hornick JL, Sholl LM, Dal Cin P, Childress MA, Lovly CM. Hornick JL, et al. Mod Pathol. 2015 May;28(5):732-9. doi: 10.1038/modpathol.2014.165. Epub 2015 Jan 23. Mod Pathol. 2015. PMID: 25612511 Free PMC article.

4

ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.

Pietrantonio F, Di Nicolantonio F, Schrock AB, Lee J, Tejpar S, Sartore-Bianchi A, Hechtman JF, Christiansen J, Novara L, Tebbutt N, Fucà G, Antoniotti C, Kim ST, Murphy D, Berenato R, Morano F, Sun J, Min B, Stephens PJ, Chen M, Lazzari L, Miller VA, Shoemaker R, Amatu A, Milione M, Ross JS, Siena S, Bardelli A, Ali SM, Falcone A, de Braud F, Cremolini C. Pietrantonio F, et al. J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx089. J Natl Cancer Inst. 2017. PMID: 29370427 Free article.

5

ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases.

Yoshida A, Kohno T, Tsuta K, Wakai S, Arai Y, Shimada Y, Asamura H, Furuta K, Shibata T, Tsuda H. Yoshida A, et al. Am J Surg Pathol. 2013 Apr;37(4):554-62. doi: 10.1097/PAS.0b013e3182758fe6. Am J Surg Pathol. 2013. PMID: 23426121

6

Clinicopathologic analysis of ROS1-rearranged non-small-cell lung cancer and proposal of a diagnostic algorithm.

Go H, Kim DW, Kim D, Keam B, Kim TM, Lee SH, Heo DS, Bang YJ, Chung DH. Go H, et al. J Thorac Oncol. 2013 Nov;8(11):1445-50. doi: 10.1097/JTO.0b013e3182a4dd6e. J Thorac Oncol. 2013. PMID: 24128715 Free article.

7

Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma.

Lim SM, Yoo JE, Lim KH, Meng Tai DW, Cho BC, Park YN. Lim SM, et al. Cancer Res Treat. 2017 Jan;49(1):185-192. doi: 10.4143/crt.2015.497. Epub 2016 Apr 27. Cancer Res Treat. 2017. PMID: 27121721 Free PMC article.

8

ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare.

Zhao W, Choi YL, Song JY, Zhu Y, Xu Q, Zhang F, Jiang L, Cheng J, Zheng G, Mao M. Zhao W, et al. Lung Cancer. 2016 Apr;94:22-7. doi: 10.1016/j.lungcan.2016.01.011. Epub 2016 Jan 21. Lung Cancer. 2016. PMID: 26973202

9

Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.

Antonescu CR, Suurmeijer AJ, Zhang L, Sung YS, Jungbluth AA, Travis WD, Al-Ahmadie H, Fletcher CD, Alaggio R. Antonescu CR, et al. Am J Surg Pathol. 2015 Jul;39(7):957-67. doi: 10.1097/PAS.0000000000000404. Am J Surg Pathol. 2015. PMID: 25723109 Free PMC article.

10

Detection of ROS1-positive non-small cell lung cancer on cytological specimens using immunocytochemistry.

Vlajnic T, Savic S, Barascud A, Baschiera B, Bihl M, Grilli B, Herzog M, Rebetez J, Bubendorf L. Vlajnic T, et al. Cancer Cytopathol. 2018 Jun;126(6):421-429. doi: 10.1002/cncy.21983. Epub 2018 Feb 16. Cancer Cytopathol. 2018. PMID: 29451745 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed